Technologies
Innovative technical and a variety of pipelines
“One-stop” gene and cell platform, covering all core technologies for CAR-T cell production
For HEMATOLOGICAL MALIGNANCIES
| Product | Indications | Pre-clinical | Exploring Clinical | IND | Phase Ⅰ | Phase Ⅱ | NDA | |
| IM19 | DLBCL | |||||||
| IM19 | B-ALL | |||||||
| IM19 | MCL | |||||||
| IM21 | Multiple Myeloma | |||||||
| IM23 | AML | |||||||
| IM03 | PTCL | |||||||
| Allogeneic Products | ||||||||
| IMET02 （Strategic Cooperation：EdiGene） |
NHL | |||||||
For SOLID TUMORS
| Product | Indications | Pre-clinical | Exploring Clinical | IND | Phase Ⅰ | Phase Ⅱ | NDA | |
| IM83 | Hepatocellular Carcinoma | |||||||
| IM18 | Melanoma | |||||||
| IM92 | Gastric Cancer & Pancreatic Cancer | |||||||
| IM96 | Carcinoma of Colon and Rectum |
